Table 3 JIA Disease Activity vs. 14–3-3η
From: Prevalence and significance of serum 14–3-3η in juvenile idiopathic arthritis
Disease activity | # Positive 14–3-3η | Total # | p-Value |
|---|---|---|---|
OJIA | |||
Inactive | 6 (30%) | 20 | 0.59 |
Mild | 0 (0%) | 7 | |
Moderate | 1 (20%) | 5 | |
Severe | 1 (25%) | 4 | |
PJIA RF- | |||
Inactive | 0 (0%) | 10 | 0.81 |
Mild | 2 (20%) | 10 | |
Moderate | 0 (0%) | 8 | |
Severe | 1 (9%) | 11 | |
PJIA RF+ | |||
Inactive | 2 (25%) | 8 | 0.59 |
Mild | 8 (67%) | 12 | |
Moderate | 5 (45%) | 11 | |
Severe | 4 (50%) | 8 | |
PsA | |||
Inactive | 0 (0%) | 6 | 0.61 |
Mild | 1 (17%) | 6 | |
Moderate | 1 (20%) | 5 | |
Severe | 0 (0%) | 2 | |
ERA | |||
Inactive | 1 (11%) | 9 | 1 |
Mild | 0 (0%) | 2 | |
Moderate | 1 (20%) | 5 | |
Severe | 0 (0%) | 2 | |